Related Experiment Video
Updated: Jan 29, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Intraluminal therapy for Helicobacter pylori infection
Tai-Cherng Liou1,2,3, Po-Hao Liao1,3, Yu-Chun Lin1,3
1Division of Gastroenterology, Department of Internal Medicine, MacKay Memorial Hospital, New Taipei City, Taiwan.
A novel intraluminal therapy for Helicobacter pylori (H. pylori) infection was developed. This approach achieved a 53.7% eradication rate in treatment-naïve patients, showing promise for a new therapeutic strategy.
Area of Science:
- Gastroenterology
- Microbiology
- Pharmacology
Background:
- Increasing antibiotic resistance in Helicobacter pylori necessitates alternative eradication strategies.
- Current oral therapies face challenges due to widespread resistance.
- Novel therapeutic approaches are crucial for effective H. pylori infection management.
Purpose of the Study:
- To develop and evaluate a novel intraluminal therapy for H. pylori infection (ILTHPI).
- To assess the safety and efficacy of ILTHPI in treatment-naïve patients.
- To explore a single-dose regimen for immediate H. pylori eradication during endoscopy.
Main Methods:
- 100 H. pylori-infected, treatment-naïve patients underwent endoscopic ILTHPI.
- ILTHPI involved pH control, mucolytic irrigation, and single-dose antibiotic powders.
- Efficacy assessed by 13C-urea breath test; safety and recurrence evaluated via stool antigen tests.
Main Results:
- ILTHPI demonstrated good safety with mild adverse events (6%).
- Immediate eradication was achieved in 53.7% (51/95) of patients.
- No short-term recurrence was observed in successfully treated patients over 4-6 months.
Conclusions:
- A novel intraluminal therapy for H. pylori infection (ILTHPI) has been successfully developed.
- ILTHPI offers a potential single-dose regimen for immediate eradication during endoscopic procedures.
- This approach addresses the need for alternative therapies due to rising antibiotic resistance.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

